PTC Therapeutics

Filed a patent for "heterocyclic and heteroaryl compounds as inhibitors of nlrp3" on Fri, December 30, 2022

Filed a patent for "crystalline forms of 2-[3-(2,2,6,6-tetramethylpiperidin-4-yl)-3h-[1,2,3]triazolo[4,5-c]pyridazin-6-yl]-5-(2h-1,2,3-triazol-2-yl)phenol" on Tue, May 9, 2023

Filed a patent for "heterocyclic and heteroaryl compounds as inhibitors of nlrp3" on Fri, May 19, 2023

Filed a patent for "methods for treating neurogenerative diseases" on Wed, March 6, 2024

Filed a patent for "methods for treating neurogenerative diseases" on Wed, March 6, 2024

Filed a patent for "methods for treating neurogenerative diseases" on Wed, March 6, 2024

Filed a patent for "heteroaryl compounds for treating huntington's disease" on Mon, January 29, 2024

Filed a patent for "rna splicing modulation" on Thu, February 16, 2023

Filed a patent for "pharmaceutical compositions comprising 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione" on Thu, January 26, 2023

Filed a patent for "methods for modulating rna splicing" on Tue, August 9, 2022

Filed a patent for "methods for modulating rna splicing" on Thu, October 5, 2023

Filed a patent for "tablet for use in treating huntington's disease and method of making the same" on Thu, December 21, 2023

Filed a patent for "inhibitors of nlrp3" on Tue, June 6, 2023

Filed a patent for "compounds for treating huntington's disease" on Thu, October 19, 2023

Filed a patent for "2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders" on Thu, October 26, 2023

Filed a patent for "methods for treating spinocerebellar ataxia type 3" on Thu, February 8, 2024

Filed a patent for "methods for treating spinocerebellar ataxia type 3" on Thu, February 15, 2024

Filed a patent for "methods for treating spinocerebellar ataxia type 3" on Thu, February 8, 2024

Filed a patent for "methods for treating glioblastomas with sepiapterin" on Thu, April 11, 2024

Filed a patent for "pharmaceutical compositions comprising sepiapterin and uses thereof" on Thu, March 28, 2024

Filed a patent for "polymorphs of sepiapterin and salts thereof" on Thu, February 8, 2024

Filed a patent for "gene therapy of ush2a retinopathy" on Mon, March 21, 2022

Filed a patent for "gene therapy of ush2a retinopathy" on Fri, May 20, 2022

Filed a patent for "compounds for treating familial dysautonomia" on Thu, February 23, 2023

Filed a patent for "heterocyclic and heteroaryl compounds for treating huntington's disease" on Wed, June 15, 2022